Results 1 - 25 from 50 for "drug"
-
Romanian Consumers Spent EUR1.4B on OTC Drugs in 2022
02.03.2023
Sales of over-the-counter (OTC) drugs reached RON6.7 billion (almost EUR1.4 billion) in 2022, up 23% from the previous year, data from market research company Cegedim show. more
-
Terapia Cluj Plans to Complete EUR5.5-5.8M Investments in Romania by Yearend
03.03.2022
Dragos Damian, CEO of one of Romania’s major drug makers, Terapia Cluj, says the company plans to carry out investments worth EUR5.5-5.8 million in Romania. more
-
Biofarm Inaugurates Second Drug Plant In Bucharest In Over EUR35M Investment
11.02.2021
Pharmaceutical manufacturer Biofarm (BIO.RO) has inaugurated a new pharmaceutical manufacturing and testing facility in capital Bucharest, which entailed an investment of over EUR35 million. more
-
Antibiotice Iasi Earmarks RON93M for Investments in 2021
06.11.2021
Pharmaceutical producer Antibiotice budgeted RON93 million investments for 2021, RON10 million more than in 2020, mainly to develop new facilities at its plant in Iasi. more
-
Vetro Solutions Invests EUR4.5M In Veterinary Drug Factory In Iasi
11.11.2020
Vetro Solutions, a distributor of veterinary drugs and services, on Wednesday said it is investing EUR4.5 million in a veterinary drug factory that will be built in Iasi until 2021. more
-
Medicine Sales in Pharmacies, Hospitals Grow 11% in Value in 2019, to RON17.8B
02.05.2020
The value of medicine sold in pharmacies and in hospitals amounted to RON17.82 billion at wholesale prices in 2019 , up 10.9% compared with 2018, according to an analysis by Cegedim Customer more
-
Terapia CEO: Clawback Tax, Skilled Human Resource Deficit- Main Challenges For Local Drug Producers
09.16.2019
-
Pharmaceutical Sales Reach EUR3B In 2017, Double 2008 Level
09.06.2018
The pharmaceutical market doubled in ten years. Medicine consumption is rising at a rate of 10% a year and pharmacies are everywhere. The government provides EUR1.5 billion subsidies. Romanians bought more
-
Antibiotice Iasi GM: Romania Has Europe's Lowest Drug Prices And World's Highest Clawback Tax
09.13.2017
-
Turmoil On Pharmaceutical Market: Manufacturers No Longer Import Drugs And Vaccines Because Of Price
02.28.2017
The major international pharmaceutical companies, whose revenue in Romania is in the range of hundreds of millions of euros, have been withdrawing thousands of drugs from the market, including more
-
Top Five OTC Drugs In Romania See EUR74M Sales
10.25.2016
The best-selling over the counter (OTC) drugs in Romania are Nurofen of Reckitt Benckiser, followed by Aspenter (Terapia Cluj), Parasinus (GlaxoSmithKline) and No-Spa (Sanofi), according to the data more
-
Pharmaceutical Market Sees First Decline In Ten Years
02.11.2016
Sales of pharmaceutical drugs fell by 4.7% to 11.7 billion lei (EUR2.6 billion) last year (January-December), according to market research company Cegedim Romania data. This is the first decline for more
-
ZF Pharma Summit ’15: Pharmaceutical Industry Hurt By Drug Price Cuts
09.23.2015
The decline in drug prices, the constant increase in the clawback tax and the lack of transparency about how it is managed are affecting the pharmaceutical market in Romania. more
-
Clawback Tax Could Drop To 5% As Drug Prices Are Lowered
05.26.2015
The clawback tax could drop to 5%, as prices of medicines are lowered, health Insurance House president Vasile Ciurchea said Tuesday. more
-
Pharmaceutical Producers Pin Hopes On OTC Drugs And Exports For Growth
04.27.2015
The five largest pharmaceutical producers in Romania posted slight growth of merely 2% to 2 billion lei (EUR453 million) on a market that increased by almost 7% in 2014 and are bracing themselves for more
-
Farmexpert: Focus Is On Regional Pharmacies
01.23.2015
Regional pharmacy chains operating in one or two counties of Romania have been gaining ground lately and have now come to directly compete with national ones, says Iulian Trandafir, general manager of more
-
New Head Of Europharm Distributie Wants To Triple The Wholesaler’s Revenue In Five Years
01.07.2015
Romanian executive Adrian Vasiliu, appointed at the helm of drug wholesaler Europharm Distributie in early November 2014, after spending the previous five years in Africa working in consumer goods more
-
Novartis Set To Create New Jobs In Romania In 2015
12.10.2014
In 2014, Swiss group Novartis registered a “modest” revenue increase in Romania amid a challenging year in the healthcare industry, estimates Elena Mitova, general manager of Novartis Pharma more
-
Main Brands On Romania’s Generic Drugs Market
12.02.2014
Sales of generic drugs, which account for 28% of the overall drug market, reached RON3.3 billion in the first nine months of this year, with prescription drugs holding the biggest weight, of above more
-
Dan Ivan, Actavis: We Thoroughly Changed Our Business Model
11.17.2014
Retail sales (via pharmacies) are now at more than 60% of the total at the moment, because of a decision made to change the business model at the end of 2011, says Dan Ivan, general manager of more
-
Romania Ranks 5th In Europe By Pharmacy Density
10.28.2014
The number of retail pharmacies has doubled in Romania in the past decade, and the issue of pharmacy numbers is being discussed again this year, as the demographic criterion regulating it is due to more
-
Businessman Mihai Miron Bets EUR2M On Production Lab In Chisinau
09.09.2014
Romanian businessman Mihai Miron, known through the companies he developed in the pharmaceutical industry, Europharm and Ropharma, has a new bet this year, a production lab in Chisinau (the Republic more
-
Romania’s Drug Wholesale Sector Gained EUR1.4B During The Crisis
09.04.2014
The 1,600 drug wholesalers registered in Romania generated overall revenue of 23.4 billion lei (EUR5.3 billion) last year, up 60% against 2008, the best year for the Romanian economy. more
-
Pharmaceutical Drug Sales Up In Q2
08.11.2014
Sales of pharmaceutical drugs returned to growth in the second quarter of the year, reaching 3 billion lei (almost EUR680 million), according to market research company Cegedim Romania. more
-
20 Largest Domestic Drug Makers Still Unable To Call The Shots On Drug Market
06.11.2014
On a domestic drug market worth over EUR2.6 billion, Romanian drug makers are unable to gain ground, with the pharmaceutical industry being traditionally dominated by importers. Hungary, the Czech more